Stocks that have missed out on this year’s market rally could be solid contenders for a rebound, according to Goldman Sachs. The
Tag: Pfizer Inc
An overlooked corner of women’s health may be $350 billion market opportunity
Peathegee Inc | Tetra Images | Getty Images After years of being ignored, menopause has entered the public conversation. Celebrities from Drew
Viking Therapeutics weight loss drug shows promising trial results
Cr | Istock | Getty Images Shares of Viking Therapeutics soared about 80% on Tuesday after the company’s experimental weight loss drug
These option plays can hedge against a reversal in stock market momentum, Goldman says
The market rally found its footing once again after Nvidia ‘s earnings report this week, but investors may still want to prepare
RIVN, DKNG, NIO, CVNA & more
Here are Friday’s biggest calls on Wall Street: UBS double-downgrades Rivian The firm said to sell the electric vehicle maker’s stock, joining
Spend money to make money
Google CEO Sundar Pichai, arrives for a US Senate bipartisan Artificial Intelligence (AI) Insight Forum at the US Capitol in Washington, DC,
Wall Street big week ahead with mega-cap earnings, Fed meeting in focus
Next week is shaping up to be the most important one of 2024 thus far for Wall Street. Investors are headed into
Fed meeting, labor report, Big Tech earnings
CNBC’s Jim Cramer on Friday looked to next week’s happenings on Wall Street, laying out how to prepare for a slew of
AI will be fine regardless of U.S. election outcome
Sam Altman, chief executive officer of OpenAI, at the Hope Global Forums annual meeting in Atlanta, Georgia, US, on Monday, Dec. 11,
AI models don’t need publishers’ data
Sam Altman, CEO of OpenAI, attends the 54th annual meeting of the World Economic Forum, in Davos, Switzerland, January 18, 2024. Denis
No More Posts Available.
No more pages to load.